Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Milton

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Epidemiology and Infection|April 6, 2004
A diagnostic strategy to determine the Shiga toxin-producing Escherichia coli O157 status of pens of feedlot cattleD R Smith, J T Gray, R A Moxley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapyVicki Leigh Keedy, Sarah Temin, Mark R Somerfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimusGregory J Riely, Mark G Kris, Binsheng Zhao, et al.
Cancer|August 1, 2006
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerDaniel T Milton, Christopher G Azzoli, Robert T Heelan, et al.
The British Journal of Nutrition|May 3, 2026
Optimising Nutritional Psychiatry Treatment: Investigating the Mediterranean Diet to Improve Symptoms of Major Depressive Disorder (OPTIMISM): A double-blind sham-controlled randomised feeding trial protocolD S Y Tien, M Hockey, K Muller, et al.
Cancer|June 20, 2007
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancerDaniel T Milton, Gregory J Riely, Christopher G Azzoli, et al.
Journal of Chromatography. A|December 22, 2009
Microfabricated planar glass gas chromatography with photoionization detectionAlastair C Lewis, Jacqueline F Hamilton, Christopher N Rhodes, et al.
The Journal of Chemical Physics|September 17, 2005
Resonance contributions to anti-Stokes/Stokes ratios under surface enhanced Raman scattering conditionsR C Maher, J Hou, L F Cohen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levelsLee M Krug, Daniel T Milton, Achim A Jungbluth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancerGregory J Riely, Naiyer A Rizvi, Mark G Kris, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Epidemiology and Infection|April 6, 2004
A diagnostic strategy to determine the Shiga toxin-producing Escherichia coli O157 status of pens of feedlot cattleD R Smith, J T Gray, R A Moxley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapyVicki Leigh Keedy, Sarah Temin, Mark R Somerfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimusGregory J Riely, Mark G Kris, Binsheng Zhao, et al.
Cancer|August 1, 2006
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerDaniel T Milton, Christopher G Azzoli, Robert T Heelan, et al.
The British Journal of Nutrition|May 3, 2026
Optimising Nutritional Psychiatry Treatment: Investigating the Mediterranean Diet to Improve Symptoms of Major Depressive Disorder (OPTIMISM): A double-blind sham-controlled randomised feeding trial protocolD S Y Tien, M Hockey, K Muller, et al.
Cancer|June 20, 2007
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancerDaniel T Milton, Gregory J Riely, Christopher G Azzoli, et al.
Journal of Chromatography. A|December 22, 2009
Microfabricated planar glass gas chromatography with photoionization detectionAlastair C Lewis, Jacqueline F Hamilton, Christopher N Rhodes, et al.
The Journal of Chemical Physics|September 17, 2005
Resonance contributions to anti-Stokes/Stokes ratios under surface enhanced Raman scattering conditionsR C Maher, J Hou, L F Cohen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levelsLee M Krug, Daniel T Milton, Achim A Jungbluth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancerGregory J Riely, Naiyer A Rizvi, Mark G Kris, et al.
Pageof 8